KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Equity Ratio (2016 - 2025)

Boston Scientific (BSX) has disclosed Equity Ratio for 17 consecutive years, with 0.56 as the latest value for Q4 2025.

  • Quarterly Equity Ratio changed 0.33% to 0.56 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.56 through Dec 2025, changed 0.33% year-over-year, with the annual reading at 0.56 for FY2025, 0.33% changed from the prior year.
  • Equity Ratio hit 0.56 in Q4 2025 for Boston Scientific, up from 0.55 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.62 in Q4 2021 to a low of 0.07 in Q2 2021.
  • Historically, Equity Ratio has averaged 0.27 across 5 years, with a median of 0.3 in 2021.
  • Biggest YoY gain for Equity Ratio was 112168.11% in 2021; the steepest drop was 13194.61% in 2021.
  • Year by year, Equity Ratio stood at 0.62 in 2021, then plummeted by 111.18% to 0.07 in 2022, then soared by 901.76% to 0.56 in 2023, then rose by 0.48% to 0.56 in 2024, then rose by 0.33% to 0.56 in 2025.
  • Business Quant data shows Equity Ratio for BSX at 0.56 in Q4 2025, 0.55 in Q3 2025, and 0.0 in Q2 2025.